Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) α and δ and PPAR coactivator 1α in human skeletal muscle, but not lipid regulatory genes

Journal of Molecular Endocrinology

Volumn 33, Issue 2, 2004, Pages 533-544

  Watt, Matthew J ^a   Southgate, R J ^a   Holmes, A G ^a   Febbraio, M A ^a  

^a RMIT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CARNITINE PALMITOYLTRANSFERASE; CD36 ANTIGEN; FATTY ACID; HORMONE SENSITIVE LIPASE; LIPID; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PYRUVATE DEHYDROGENASE; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHR;

ADRENALIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LIPID METABOLISM; MUSCLE EXERCISE; MYOTUBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE; TISSUE DISTRIBUTION; UPREGULATION;

ANTIGENS, CD36; ANTILIPEMIC AGENTS; CALCIMYCIN; CARNITINE O-PALMITOYLTRANSFERASE; CELLS, CULTURED; CHOLESTEROL ESTERASE; ENZYME INHIBITORS; EPINEPHRINE; EXERCISE TEST; FATTY ACIDS; FORKHEAD TRANSCRIPTION FACTORS; HEAT-SHOCK PROTEINS; HUMANS; IMIDAZOLES; LIPIDS; MUSCLE, SKELETAL; NIACIN; NUCLEAR PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PPAR ALPHA; PPAR DELTA; PROTEIN KINASES; PYRIDINES; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 7244238303     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.01499     Document Type: Article

References (50)

1. Alvarsson M & Grill V 1996 Impact of nicotinic acid treatment on insulin secretion and insulin sensitivity in low and high insulin responders. Scandanavian Journal of Clinical and Laboratory Investigations 56 563-570.
2. Baar K, Wende AR, Jones TE, Marison M, Nolte LA, Chen M, Kelly DP & Holloszy JO 2002 Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB Journal 16 1879-1886.
3. Baar K, Song Z, Semenkovich CF, Jones TE, Han DH, Nolte LA, Ojuka EO, Chen M & Holloszy JO 2003 Skeletal muscle overexpression of nuclear respiratory factor 1 increases glucose transport capacity. FASEB Journal 17 1666-1673.
4. Berthon PM, Howlett RA, Heigenhauser GJ & Spriet LL 1998 Human skeletal muscle carnitine palmitoyltransferase I activity determined in isolated intact mitochondria. Journal of Applied Physiology 85 148-153.
5. Bonen A, Dyck DJ, Ibrahimi A & Abumrad NA 1999 Muscle contractile activity increases fatty acid metabolism and transport and FAT/CD36. American Journal of Physiology 276 E642-E649.
6. Braissant O, Foufelle F, Scotto C, Dauca M & Wahli W 1996 Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137 354-366.
7. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J & Greenberg ME 1999 Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96 857-868.
8. Chomczynski P & Sacchi N 1987 Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162 156-159.
9. Cortright RN, Zheng D, Jones JP, Fluckey JD, DiCarlo SE, Grujic D, Lowell BB & Dohm GL 1999 Regulation of skeletal muscle UCP-2 and UCP-3 gene expression by exercise and denervation. American Journal of Physiology 276 E217-E221.
10. Djouadi F, Weinheimer CJ, Saffitz JE, Pitchford C, Bastin J, Gonzalez FJ & Kelly DP 1998 A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor alpha-deficient mice. Journal of Clinical Investigation 102 1083-1091.
11. Dressel U, Allen TL, Pippal JB, Rohde PR, Lau P & Muscat GE 2003 The peroxisome proliferator-activated receptor β/δ agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Molecular Endocrinology 17 2477-2493.
12. Fan M, Rhee J, St-Pierre J, Handschin C, Puigserver P, Lin J, Jaeger S, Erdjument-Bromage H, Tempst P & Spiegelman B 2003 Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1: modulation by p38 MAPK. Genes and Development 18 278-289.
13. Febbraio MA & Koukoulas I 2000 HSP72 gene expression progressively increases in human skeletal muscle during prolonged, exhaustive exercise. Journal of Applied Physiology 89 1055-1060.
14. Goto M, Terada S, Kato M, Katoh M, Yokozeki T, Tabata I & Shimokawa T 2000 cDNA cloning and mRNA analysis of PGC-1 in epitrochlearis muscle in swimming-exercised rats. Biochemical and Biophysical Research Communications 274 350-354.
15. Gulick T, Cresci S, Caira T, Moore DD & Kelly DP 1994 The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. PNAS 91 11012-11016.
16. Hood DA 2001 Invited review: Contractile activity-induced mitochondrial biogenesis in skeletal muscle. Journal of Applied Physiology 90 1137-1157.
17. Horowitz JF, Leone TC, Feng W, Kelly DP & Klein S 2000 Effect of endurance training on lipid metabolism in women: a potential role for PPARalpha in the metabolic response to training. American Journal of Physiology. Endocrinology and Metabolism 279 E348-E355.
18. Huang B, Wu P, Bowker-Kinley MM & Harris RA 2002 Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin. Diabetes 51 276-283.
19. Ichida M, Nemoto S & Finkel T 2002 Identification of a specific molecular repressor of the peroxisome proliferator-activated receptor γ coactivator a (PGC-1 a). Journal of Biological Chemistry 277 50991-50995.
20. Kelley DE, Goodpaster BH & Storlien L 2002 Muscle triglyceride and insulin resistance. Annual Review of Nutrition 22 325-346.
21. Kliewer SA, Xu HE, Lambert MH & Willson TM 2001 Peroxisome proliferator-activated receptors: from genes to physiology. Recent Progress in Hormone Research 56 239-263.
22. Knutti D, Kressler D & Kralli A 2001 Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor. PNAS 98 9713-9718.
23. Koh EH, Kim MS, Park JY, Kim HS, Youn JY, Park HS, Youn JH & Lee KU 2003 Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation. Diabetes 52 2331-2337.
24. Larrouy D, Vidal H, Andreelli F, Laville M & Langin D 1999 Cloning and mRNA tissue distribution of human PPARgamma coactivator-1. International Journal of Obesity and Related Metabolic Disorders 23 1327-1332.
25. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D & Groop LC 2003 PGC-1α responsive genes involved in oxidative phosphorylation are co-ordinately downregulated in human diabetes. Nature Genetics 34 267-273.
26. Muoio DM, Way JM, Tanner CJ, Winegar DA, Kliewer SA, Houmard JA, Kraus WE & Dohm GL 2002 Peroxisome proliferator-activated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells. Diabetes 51 901-909.
27. Norrbom J, Sundberg CJ, Ameln H, Kraus WE, Jansson E & Gustafsson T 2004 PGC-1α mRNA expression is influenced by metabolic perturbation in exercising human skeletal muscle. Journal of Applied Physiology 96 189-194.
28. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR & Mandarino LJ 2003 Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC-1 and NRF-1. PNAS 100 8466-8471.
29. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW & Shulman GI 2003 Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300 1140-1142.
30. Phillips SM, Green HJ, Tarnopolsky MA, Heigenhauser GF, Hill RE & Grant SM 1996 Effects of training duration on substrate turnover and oxidation during exercise. Journal of Applied Physiology 81 2182-2191.
31. Pilegaard H, Ordway GA, Saltin B & Neufer PD 2000 Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise. American Journal of Physiology. Endocrinology and Metabolism 279 E806-E814.
32. Pilegaard H, Keller C, Steensberg A, Helge JW, Pedersen BK, Saltin B & Neufer PD 2002 Influence of pre-exercise muscle glycogen content on exercise-induced transcriptional regulation of metabolic genes. Journal of Physiology 541 261-271.
33. Pilegaard H, Saltin B & Neufer PD 2003 Exercise induces transient transcriptional activation of the PGC-1α gene in human skeletal muscle. Journal of Physiology 546 851-858.
34. Puigserver P & Spiegelman BM 2003 Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α): transcriptional coactivator and metabolic regulator. Endocrine Reviews 24 78-90.
35. Puigserver P, Wu Z, Park CW, Graves R, Wright M & Spiegelman BM 1998 A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92 829-839.
36. Puigserver P, Rhee J, Lin J, Wu Z, Yoon JC, Zhang CY, Krauss S, Mootha VK, Lowell BB & Spiegelman BM 2001 Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Molecular Cell 8 971-982.
37. Russell AP, Feilchenfeldt J, Schreiber S, Praz M, Crettenand A, Gobelet C, Meier CA, Bell DR, Kralli A, Giacobino JP & Deriaz O 2003 Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle. Diabetes 52 2874-2881.
38. Short KR, Vittone JL, Bigelow ML, Proctor DN, Rizza RA, Coenen-Schinike JM & Nair KS 2003 Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 52 1888-1896.
39. Spina RJ, Chi MM, Hopkins MG, Nemeth PM, Lowry OH & Holloszy JO 1996 Mitochondrial enzymes increase in muscle in response to 7-10 days of cycle exercise. Journal of Applied Physiology 80 2250-2254.
40. Terada S & Tabata I 2004 Effects of acute bouts of running and swimming exercise on PGC-1α protein expression in rat epitrochlearis and soleus muscle. American Journal of Physiology. Endocrinology and Metabolism 286 E208-E216.
41. Terada S, Goto M, Kato M, Kawanaka K, Shimokawa T & Tabata I 2002 Effects of low-intensity prolonged exercise on PGC-1 mRNA expression in rat epitrochlearis muscle. Biochemical and Biophysical Research Communications 296 350-354.
42. Tunaru S, Kero J, Schaub A, Wufka C, Blaukat A, Pfeffer K & Offermanns S 2003 PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nature Medicine 9 352-355.
43. Tunstall RJ, Mehan KA, Wadley GD, Collier GR, Bonen A, Hargreaves M & Cameron-Smith D 2002 Exercise training increases lipid metabolism gene expression in human skeletal muscle. American Journal of Physiology. Endocrinology and Metabolism 283 E66-E72.
44. Vega RB, Huss JM & Kelly DP 2000 The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Molecular and Cellular Biology 20 1868-1876.
45. van der Vusse GJ & Reneman RS 1996 Lipid metabolism in muscle. In Handbook of Physiology: Exercise: Regulation and Integration of Multiple Systems, pp 952-994. Eds LB Rowell & JT Shephard. New York: Oxford Press.
46. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H & Evans RM 2003 Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 113 159-170.
47. Watt MJ, Heigenhauser GJF, O'Neill M & Spriet LL 2003 Hormone sensitive lipase activity and fatty acyl CoA content in human skeletal muscle during prolonged exercise. Journal of Applied Physiology 95 314-321.
48. Watt MJ, Holmes AG Steinberg GR, Mesa JL, Kemp BE & Febbraio MA 2004 Reduced plasma FFA availability increases net triacylglycerol degradation, but not GPAT or HSL activity, in human skeletal muscle. American Journal of Physiology Endocrinology and Metabolism 287 E120-127.
49. Wu P, Inskeep K, Bowker-Kinley MM, Popov KM & Harris RA 1999 Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes 48 1593-1599.
50. Zong H, Ren JM, Young LH, Pypaert M, Mu J, Birnbaum MJ & Shulman GI 2002 AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. PNAS 99 15983-15987.